Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2/neu-positive urothelial carcinoma: results of a multicenter phase II National Cancer Institute trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples